South West Sydney Local Health District
21
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.5%
2 terminated/withdrawn out of 21 trials
80.0%
-6.5% vs industry average
10%
2 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
Role: lead
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Role: lead
Rehabilitation in the Home After Hip Fracture
Role: lead
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
Role: lead
The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence
Role: lead
Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients
Role: lead
Renin as a Biomarker of Haemodynamic Normalisation
Role: lead
Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
Role: lead
The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence
Role: lead
Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
Role: lead
Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
Role: lead
Improving Services and Outcomes for Joint Replacement Patients
Role: lead
Fluid Responsiveness After CArdiac Surgery Study
Role: lead
PINOT Follow-up Study in End-stage Kidney Disease
Role: collaborator
Walking Capacity in Parkinson's Disease (PD-Walk)
Role: collaborator
A Randomized Controlled Trial of Structured Stepped-care Intervention for Psychiatric Comorbidity
Role: lead
Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients
Role: collaborator
Patient INformation About Options for Treatment - PINOT
Role: collaborator
Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Role: lead
Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy
Role: lead